Jeffrey Langsam insider trades
Open-market stock purchases and sales by Jeffrey Langsam, Chief Clinical Officer at Oncology Institute, Inc, from SEC Form 4 filings since May 21, 2025.
Recent trades
| Date | Stock | Trade | Value |
|---|---|---|---|
| Mar 27, 2026 | TOI Oncology Institute, Inc | Bought (not open market) | — |
Companies traded
- TOI Oncology Institute, Inc: other filings, last Mar 27, 2026